medicine

medicine

Graphics: TBS

Bangladesh’s healthcare at crossroads: Progress stalled by policy failures

Bangladesh’s healthcare sector is growing fast, but weak regulation, lack of coordination and financial barriers are undermining access and equity

Photo: Bloomberg

Scientists develop breakthrough injection to repair damaged hearts

Jahanmgir Kabir, owner of JK Lifestyle. Photo: Courtesy

JK Lifestyle owner Jahangir warns against fake posts on social media

Affordable medicine key to achieving UHC in Bangladesh: Health experts

Affordable medicine key to achieving UHC in Bangladesh: Health experts

Photo: Noor-A-Alam

Health ministry works to withdraw increased VAT on medicines: Official

What gastric drug sales say about the state of our food safety

What gastric drug sales say about the state of our food safety

Dr Yun K Tam and his Bangladeshi-Canadian wife Dr Nuzhat Tam-Zaman, co-founders of Sinoveda Canada Inc. Photo: Courtesy

Canadian medicine researchers looking for manufacturing partner in Bangladesh 

Healthcare, trade, and overall cooperation between the two countries came for discussion during the meeting. Photo: UNB

Pakistan keen to import medicine from Bangladesh

Dhaka Medical College Hospital (DMCH). File photo: Collected

Short supply of medicines, syndicates rock DMCH

Renata's Cabergoline 0.5mg tablets received approval from the EU Decentralized Procedure (DCP). The medicine is sold in Bangladesh under the name Cabolin. Photo: Collected

Renata can now export drug for Parkinson's disease to Europe

Sketch: TBS

Prescribing brand names vs generic names of medicine: A dilemma and debate

Health Minister Dr Samanta Lal Sen speaks at the annual meeting of member states of South-East Asia Regulatory Network (SEARN) on 3 July 2024. Photo: PID

Health minister for maintaining standard of medicine

In Bangladesh, 69% of the total health expenditure in the country is paid out-of-pocket by patients. A large chunk of that goes into paying for medication. Photo: Reuters

Why are medicines so expensive when prices cannot be raised without approval?